Nadzan AM - Search Results

1

Hydroxynybomycin: isolation, structure and bioactivity.

Nadzan AM, Rinehart KL Jr, Sokolski WT. Nadzan AM, et al. J Antibiot (Tokyo). 1977 Jun;30(6):523-4. doi: 10.7164/antibiotics.30.523. J Antibiot (Tokyo). 1977. PMID: 885812 Free article. No abstract available.

2

Nybomycin. 9. Synthetic and biosynthetic incorporation of 15N as a means of assigning the 13C nuclear magnetic resonance spectrum of nybomycin 1,2.

Nadzan AM, Rinehart KL Jr. Nadzan AM, et al. J Am Chem Soc. 1977 Jul 6;99(14):4647-54. doi: 10.1021/ja00456a021. J Am Chem Soc. 1977. PMID: 874227 No abstract available.

3

Letter: Nybomycin. 8. Biosynthetic origin of the central ring carbons studied by 13C-labeled substrates.

Nadzan AM, Rinehart KL Jr. Nadzan AM, et al. J Am Chem Soc. 1976 Aug 4;98(16):5012-4. doi: 10.1021/ja00432a052. J Am Chem Soc. 1976. PMID: 950425 No abstract available.

4

Novel trifluoroacetophenone derivatives as malonyl-CoA decarboxylase inhibitors.

Wallace DM, Haramura M, Cheng JF, Arrhenius T, Nadzan AM. Wallace DM, et al. Among authors: nadzan am. Bioorg Med Chem Lett. 2007 Feb 15;17(4):1127-30. doi: 10.1016/j.bmcl.2006.09.023. Epub 2007 Jan 17. Bioorg Med Chem Lett. 2007. PMID: 17234415

5

Discovery of potent and orally available malonyl-CoA decarboxylase inhibitors as cardioprotective agents.

Cheng JF, Huang Y, Penuliar R, Nishimoto M, Liu L, Arrhenius T, Yang G, O'leary E, Barbosa M, Barr R, Dyck JR, Lopaschuk GD, Nadzan AM. Cheng JF, et al. Among authors: nadzan am. J Med Chem. 2006 Jul 13;49(14):4055-8. doi: 10.1021/jm0605029. J Med Chem. 2006. PMID: 16821767

6

Heteroaryl substituted bis-trifluoromethyl carbinols as malonyl-CoA decarboxylase inhibitors.

Cheng JF, Mak CC, Huang Y, Penuliar R, Nishimoto M, Zhang L, Chen M, Wallace D, Arrhenius T, Chu D, Yang G, Barbosa M, Barr R, Dyck JR, Lopaschuk GD, Nadzan AM. Cheng JF, et al. Among authors: nadzan am. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3484-8. doi: 10.1016/j.bmcl.2006.03.100. Epub 2006 Apr 27. Bioorg Med Chem Lett. 2006. PMID: 16644218

7

Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors.

Cheng JF, Chen M, Wallace D, Tith S, Haramura M, Liu B, Mak CC, Arrhenius T, Reily S, Brown S, Thorn V, Harmon C, Barr R, Dyck JR, Lopaschuk GD, Nadzan AM. Cheng JF, et al. Among authors: nadzan am. J Med Chem. 2006 Mar 9;49(5):1517-25. doi: 10.1021/jm050109n. J Med Chem. 2006. PMID: 16509570

8

Aza-retinoids as novel retinoid X receptor-specific agonists.

Farmer LJ, Marron KS, Canan Koch SS, Hwang CK, Kallel EA, Zhi L, Nadzan AM, Robertson DW, Bennani YL. Farmer LJ, et al. Among authors: nadzan am. Bioorg Med Chem Lett. 2006 May 1;16(9):2352-6. doi: 10.1016/j.bmcl.2005.12.003. Epub 2005 Dec 20. Bioorg Med Chem Lett. 2006. PMID: 16364638

9

Design and synthesis of heterocyclic malonyl-CoA decarboxylase inhibitors.

Cheng JF, Chen M, Liu B, Hou Z, Arrhenius T, Nadzan AM. Cheng JF, et al. Among authors: nadzan am. Bioorg Med Chem Lett. 2006 Feb;16(3):695-700. doi: 10.1016/j.bmcl.2005.10.020. Epub 2005 Oct 27. Bioorg Med Chem Lett. 2006. PMID: 16257202

10

Discovery and structure-activity relationship of coumarin derivatives as TNF-alpha inhibitors.

Cheng JF, Chen M, Wallace D, Tith S, Arrhenius T, Kashiwagi H, Ono Y, Ishikawa A, Sato H, Kozono T, Sato H, Nadzan AM. Cheng JF, et al. Among authors: nadzan am. Bioorg Med Chem Lett. 2004 May 17;14(10):2411-5. doi: 10.1016/j.bmcl.2004.03.022. Bioorg Med Chem Lett. 2004. PMID: 15109623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page